RACHEL VANWETTERING: Open Payments
NPI 1548965676 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 56 payments from 16 companies in 2025. Trend: 2023 $328 · 2024 $445 · 2025 $1,212
Food & beverage: $1,057Education: $155
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $249 |
| ABBVIE INC. | 22 | $244 |
| Incyte Corporation | 8 | $178 |
| Novartis Pharmaceuticals Corporation | 6 | $154 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Lilly USA, LLC | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 1 | $53 |
| Biofrontera Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| UCB, Inc. | 1 | $27 |
Products named: TREMFYA, OPZELURA, DUPIXENT, COSENTYX, SKYRIZI, RINVOQ, QULIPTA, Sotyktu.
Industry payments across NM — which companies pay providers there.
